Post-market in-vitro comparative studies of different brands of metformin tablets available in Libya
Mohamed I. Daghman, Ali M. Rafieda, Osama M. Serrar, Fatema M. Al Hedad
Abstract
Metformin hydrochloride is the first-line anti-diabetic drug used to treat type 2 diabetes mellites and helps to control blood sugar levels. Various brands of metformin are available in the Libyan market which makes it challenging to select, an effective and economical one. This study aimed to compare different brands of metformin available in the Misurata and evaluate the quality parameter according to the British Pharmacopoeia. Six brands of metformin tablets (850 mg) were taken from the market and assessed. To achieve this purpose five tests were done on each brand, the uniformity of weight test shows the average weight and 5.0% deviation, the friability test gives how much the tablet can stand attrition, the disintegration time test shows the time taken by the tablet to disintegrate, dissolution test to confirm the rate of drug release, weight variation and friability test of all brands was within the specified limit. Disintegration time for all the brands was within 30 minutes. All six brands of metformin hydrochloride tablets fulfilled the in-vitro dissolution rate test specification not less than 80% of the drug is released within 45 minutes. Using Ultraviolet-visible (UV) spectroscopy, UV analysis of different samples shows that the percentage content of active ingredients of five brands of metformin hydrochloride tablets was within the monograph specification (95%-105%) of drug content but one brand failed this test. The study indicated that strict quality control of imported drugs should enforced to ensure effective and safe medicines in the Libyan market.
Keywords
References
- Mammari N, Ibrahim W, Haroun M (2019) Comparative in-vitro evaluation of metformin HCl extended-release tablets marketed in Syria. Research Journal of Pharmacy and Technology. 12 (7): 3365-3370. doi: 10.5958/0974-360X.2019.00568.7
- Okafo SE (2020) Comparative in vitro evaluation of some brands of metformin hydrochloride tablets marketed in Southern Nigeria. East African Scholars Journal of Medical Sciences. 3 (3): 116-121. doi: 10.36349/EASMS.2020. v03i03.014
- Balamuralidhara V (2011) Comparative study of in-process and finished products quality control tests of IP, BP & USP for tablets. International Journal of Pharmacy Teaching and Practices. 2 (4): 176-183. doi: Nil.
- Chavan H, Chhabra G, Gujarathi N, Jadhav A (2018) Comparative study of in-process and finished products quality control test for tablet and capsules according to pharmacopoeias. Asian Journal of Pharmaceutical Research and Development. 6 (3): 60-68. doi: 10.22270/ajprd.v6i3.370
- Olusola AM, Adekoya AI, Olanrewaju OJ (2012) Comparative evaluation of physicochemical properties of some commercially available brands of metformin HCl tablets in Lagos, Nigeria. Journal of Applied Pharmaceutical Science. 2 (2): 41-44. doi: Nil.
- Gupta MM, Gupta M (2016) In-vitro pharmaceutical quality control testing: A comparative study of different brands of metformin tablets available in the Trinidad & Tobago, West Indies. Journal of Pharmaceutical Sciences and Research. 8 (4): 238-243. Corpus ID: 212541306.
- British Pharmacopoeia Commission (2008) British Pharmacopoeia. Midazolam injection. Great Britain. Illustrated revised. Her Majesty's Stationery Office. ISBN: 0113227507, 9780113227501.
- Hadiia GM, Albarasi H, Abdalrahman S, Alasbily HM, Elawamy HA, Alfituri AM, Jabir S, Netfa MA (2024) Metformin dosage and renal protection in type 2 diabetes: Impact on estimated glomerular filtration rate. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 4 (3): 7-14. doi. 10.5281/zenodo.13256137
- Abozaid DM, Saleh WM (2022) Evaluation of some metformin hydrochloride brands available in the Libyan market. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (4): 6-12. doi: 10.5281/zenodo. 7479690
- Almdaaf MA, Altriki MS, Elnekaib MA (2023) Post-marketing quality assessment of paracetamol brands in the Libyan market. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 3 (4): 73-79. doi: 10.5281/ zenodo.10289340
- Lakmali EMMS, Thanujah M, Thuvaragan S, Kuruppu KDA (2021) Comparative evaluation of metformin hydrochloride brands available in Sri Lanka. KDU International Research Conference. ID: 125. 58-62. doi: Nil.
- Elghnimi T, Ammar A, Saadawi S, Algeryani A (2021) Pharmaceutical evaluation of some commercial brands of metronidazole 500 mg tablets marketed in Tripoli Libya. International Journal of Science and Research. 10 (12): 94-104. doi: 10.21275/SR211130012431
- Sheorey SD, Hinge MA, Sengupta R, Menon BV (2012) Pharmaceutical equivalence between different brands of metformin Hydrochloride tablets. Journal of Pharmacy Research. 5 (6): 3456-3459. doi: Nil.
- Elfituri AA, Almoudy A, Jbouda W, Wesal Abuflaiga W, Sherif FM (2018) Libya’s pharmaceutical situation: A professional opinion. International Journal of Academic Health and Medical Research. 2 (10): 5-9. doi: Nil.
- Akter MR, Islam MS, Rana MM (2020) Comparative evaluation of in vitro physicochemical parameters of some commercially available metformin HCl 500 mg tablets in Bangladesh. International Journal of Innovative Science and Research Technology. 5 (11): 1019-1023. doi: Nil.
- Eraga SO, Arhewoh MI, Oruh EP, Iwuagwu MA, Eraga S, De A (2017) A comparative evaluation of the pharmaceutical quality of different brands of metformin hydrochloride tablets available in Abuja, Nigeria. West African Journal of Pharmacy. 28 (1): 61-71. doi: 10.60787/wapcp-28-1-137
- Eteer SA, Elbakay JA, Almashai NA, Maree HA, Elgadi SS, Almog TK (2023) A comparative evaluation of furosemide tablets marketed in Libya. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 3 (4): 83-89. doi: 10.5281/zenodo.10389843
Submitted date:
11/08/2024
Reviewed date:
11/18/2024
Accepted date:
11/25/2024
Publication date:
11/25/2024